跳至主要内容
临床试验/ISRCTN34827306
ISRCTN34827306已完成未知

Comparison of Bisoprolol and Carvedilol in elderly heart failure (HF) patients: a randomised, double-blind multicentre study

German Heart Failure Competence Network (Germany)0 个研究点目标入组 1,040 人开始时间: 2005年10月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,040

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Current inclusion criteria as of 15/01/2008:
  • 1. Age greater than or equal to 65 years
  • 2. Current diagnosis of chronic heart failure from New York Heart Association (NYHA) II - IV or ejection fraction (EF) less than 40%
  • 3. Clinically stable heart failure for 2 weeks before inclusion
  • 4. Informed consent
  • Previous inclusion criteria:
  • 1. Age greater than or equal to 65 years
  • 2. Chronic heart failure New York Heart Association (NYHA) II - IV or ejection fraction (EF) less than 40%
  • 3. Clinically stable heart failure for 2 weeks before inclusion
  • 4. Informed consent given

排除标准

  • Current exclusion criteria as of 15/01/2008:
  • Most relevant exclusion criteria:
  • 1. Acute/decompensated HF
  • 2. Shock, pulmonary embolism
  • 3. Obstructive/restrictive cardiomyopathy
  • 4. Severe pulmonary disorders/asthma
  • 5. Inflammatory heart diseases
  • 6. Standard exclusion criteria (as listed in the protocol)
  • 7. Contraindications against beta blockers (as listed in the protocol)
  • 8. Restricted concomittant medication (as listed in the protocol)
  • Previous exclusion criteria:
  • Most relevant exclusion criteria:
  • 1. Acute/decompensated HF
  • 2. Shock, pulmonary embolism
  • 3. Obstructive/restrictive cardiomyopathy
  • 4. Severe pulmonary disorders/asthma
  • 5. HTN not controlled
  • 6. Inflammatory heart diseases
  • 7. Standard exclusion criteria (as listed in the protocol)
  • 8. Contraindications against beta blockers (as listed in the protocol)
  • 9. Restricted concomittant medication (as listed in the protocol)

研究者

发起方
German Heart Failure Competence Network (Germany)

相似试验